Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance

Aim: Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer tr...

Full description

Bibliographic Details
Main Authors: Göker, M., Devoogdt, N., Van de Putte, G., Schobbens, J.C., Vlasselaer, J., Van den Broecke, R., de Jonge, E.T.M.
Format: Online
Language:English
Published: Universa Press 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987359/
id pubmed-3987359
recordtype oai_dc
spelling pubmed-39873592014-04-21 Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance Göker, M. Devoogdt, N. Van de Putte, G. Schobbens, J.C. Vlasselaer, J. Van den Broecke, R. de Jonge, E.T.M. Systematic Review Aim: Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer treatment varies due to a lack of uniform definition and measurement criteria. This review aims to determine the prevalence of BCRL following axillary lymph node dissection (ALND) as a benchmark to be used in a risk-benefit medical decision whether to proceed with ALND or not. The risk of leaving unresected non-sentinel metastatic lymph nodes with a presumed inherent risk of local recurrence will be balanced against the risk of BCRL following a potentially unnecessary ALND. Universa Press 2013 /pmc/articles/PMC3987359/ /pubmed/24753936 Text en Copyright: © 2013 Facts, Views & Vision http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Göker, M.
Devoogdt, N.
Van de Putte, G.
Schobbens, J.C.
Vlasselaer, J.
Van den Broecke, R.
de Jonge, E.T.M.
spellingShingle Göker, M.
Devoogdt, N.
Van de Putte, G.
Schobbens, J.C.
Vlasselaer, J.
Van den Broecke, R.
de Jonge, E.T.M.
Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance
author_facet Göker, M.
Devoogdt, N.
Van de Putte, G.
Schobbens, J.C.
Vlasselaer, J.
Van den Broecke, R.
de Jonge, E.T.M.
author_sort Göker, M.
title Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance
title_short Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance
title_full Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance
title_fullStr Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance
title_full_unstemmed Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance
title_sort systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance
description Aim: Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer treatment varies due to a lack of uniform definition and measurement criteria. This review aims to determine the prevalence of BCRL following axillary lymph node dissection (ALND) as a benchmark to be used in a risk-benefit medical decision whether to proceed with ALND or not. The risk of leaving unresected non-sentinel metastatic lymph nodes with a presumed inherent risk of local recurrence will be balanced against the risk of BCRL following a potentially unnecessary ALND.
publisher Universa Press
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987359/
_version_ 1612078373056544768